{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:34:31Z","timestamp":1791340471315,"version":"4.3.1"},"reference-count":43,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,11,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Peripheral T-cell lymphoma (PTCL) is a rare, heterogeneous type of non-Hodgkin lymphoma (NHL) that, in general, is associated with a poor clinical outcome. Therefore, a current major challenge is the discovery of new prognostic tools for this disease. In the present study, a cohort of 122 patients with PTCL was collected from a multicentric T-cell lymphoma consortium (TENOMIC). We analyzed the expression of 80 small nucleolar RNAs (snoRNAs) using high-throughput quantitative PCR. We demonstrate that snoRNA expression analysis may be useful in both the diagnosis of some subtypes of PTCL and the prognostication of both PTCL-not otherwise specified (PTCL-NOS; n = 26) and angio-immunoblastic T-cell lymphoma (AITL; n = 46) patients treated with chemotherapy. Like miRNAs, snoRNAs are globally down-regulated in tumor cells compared with their normal counterparts. In the present study, the snoRNA signature was robust enough to differentiate anaplastic large cell lymphoma (n = 32) from other PTCLs. For PTCL-NOS and AITL, we obtained 2 distinct prognostic signatures with a reduced set of 3 genes. Of particular interest was the prognostic value of HBII-239 snoRNA, which was significantly over-expressed in cases of AITL and PTCL-NOS that had favorable outcomes. Our results suggest that snoRNA expression profiles may have a diagnostic and prognostic significance for PTCL, offering new tools for patient care and follow-up.<\/jats:p>","DOI":"10.1182\/blood-2012-06-438135","type":"journal-article","created":{"date-parts":[[2012,9,19]],"date-time":"2012-09-19T03:11:28Z","timestamp":1348024288000},"page":"3997-4005","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":72,"title":["Small nucleolar RNA expression profiling identifies potential prognostic markers in peripheral T-cell lymphoma"],"prefix":"10.1182","volume":"120","author":[{"given":"Wilfried","family":"Valleron","sequence":"first","affiliation":[{"name":"Cancer Research Center of Toulouse, Toulouse, France;"},{"name":"University Paul Sabatier, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Ysebaert","sequence":"additional","affiliation":[{"name":"Cancer Research Center of Toulouse, Toulouse, France;"},{"name":"Department of Haematology, Centre Hospitalier Universitaire (CHU) Purpan, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Berquet","sequence":"additional","affiliation":[{"name":"Cancer Research Center of Toulouse, Toulouse, France;"},{"name":"University Paul Sabatier, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Fataccioli","sequence":"additional","affiliation":[{"name":"Department of Pathology and Inserm U955, H\u00f4pital Henri Mondor, Universit\u00e9 Paris-Est, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Quelen","sequence":"additional","affiliation":[{"name":"Cancer Research Center of Toulouse, Toulouse, France;"},{"name":"University Paul Sabatier, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Pathology, CHU de Bobigny, Bobigny, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Parrens","sequence":"additional","affiliation":[{"name":"Department of Pathology, H\u00f4pital Haut-L\u00e9v\u00e8que, Pessac, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Lamant","sequence":"additional","affiliation":[{"name":"Department of Pathology CHU Purpan, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"de Leval","sequence":"additional","affiliation":[{"name":"Department of Clinical Pathology, Institut Universitaire de Pathologie de Lausanne, Lausanne, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gisselbrecht","sequence":"additional","affiliation":[{"name":"Department of Haematology, H\u00f4pital Saint-Louis, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gaulard","sequence":"additional","affiliation":[{"name":"Department of Pathology and Inserm U955, H\u00f4pital Henri Mondor, Universit\u00e9 Paris-Est, Cr\u00e9teil, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Brousset","sequence":"additional","affiliation":[{"name":"Cancer Research Center of Toulouse, Toulouse, France;"},{"name":"University Paul Sabatier, Toulouse, France;"},{"name":"Department of Pathology CHU Purpan, Toulouse, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"3","key":"2019111808211012000_B1","first-page":"83","article-title":"WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview.","volume":"102","author":"Sabattini","year":"2010","journal-title":"Pathologica"},{"issue":"5","key":"2019111808211012000_B2","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","article-title":"Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.","volume":"115","author":"Iqbal","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111808211012000_B3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00277-008-0544-2","article-title":"Clinical features and prognostic factors of patients with \u2018peripheral T cell lymphoma, unspecified\u2019.","volume":"88","author":"Lee","year":"2009","journal-title":"Ann Hematol"},{"issue":"8","key":"2019111808211012000_B4","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","article-title":"Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification.","volume":"9","author":"L\u00f3pez-Guillermo","year":"1998","journal-title":"Ann Oncol"},{"issue":"9","key":"2019111808211012000_B5","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"issue":"4","key":"2019111808211012000_B6","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11899-010-0062-x","article-title":"Prognostic markers in peripheral T-cell lymphoma.","volume":"5","author":"Piccaluga","year":"2010","journal-title":"Curr Hematol Malig Rep"},{"issue":"16","key":"2019111808211012000_B7","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":"Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019111808211012000_B8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.critrevonc.2009.01.002","article-title":"Molecular classification of T-cell lymphomas.","volume":"72","author":"de Leval","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"issue":"6","key":"2019111808211012000_B9","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type.","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"key":"2019111808211012000_B10","article-title":"International Agency for Research on Cancer.","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue","author":"Swerdlow","year":"2008"},{"issue":"25","key":"2019111808211012000_B11","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes.","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111808211012000_B12","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"International Peripheral T-Cell Lymphoma Project. ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"issue":"7043","key":"2019111808211012000_B13","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers.","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"issue":"11","key":"2019111808211012000_B14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers.","volume":"6","author":"Calin","year":"2006","journal-title":"Nature Reviews Cancer"},{"key":"2019111808211012000_B15","volume-title":"Small RNAs: Analysis and Regulatory Functions","author":"Nellen","year":"2005"},{"issue":"8","key":"2019111808211012000_B16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0300-9084(02)01402-5","article-title":"The expanding snoRNA world.","volume":"84","author":"Bachellerie","year":"2002","journal-title":"Biochimie"},{"issue":"6","key":"2019111808211012000_B17","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0300-9084(96)84751-1","article-title":"Processing of fibrillarin-associated snoRNAs from pre-mRNA introns: an exonucleolytic process exclusively directed by the common stem-box terminal structure.","volume":"78","author":"Cavaill\u00e9","year":"1996","journal-title":"Biochimie"},{"issue":"5","key":"2019111808211012000_B18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/j.1460-2075.1996.tb00450.x","article-title":"Processing of the intron-encoded U16 and U18 snoRNAs: the conserved C and D boxes control both the processing reaction and the stability of the mature snoRNA.","volume":"15","author":"Caffarelli","year":"1996","journal-title":"EMBO J"},{"issue":"11","key":"2019111808211012000_B19","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1101\/gad.9.11.1411","article-title":"Exonucleolytic processing of small nucleolar RNAs from pre-mRNA introns.","volume":"9","author":"Kiss","year":"1995","journal-title":"Genes Dev"},{"issue":"22","key":"2019111808211012000_B20","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1038\/onc.2011.449","article-title":"Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis.","volume":"31","author":"Mei","year":"2012","journal-title":"Oncogene"},{"issue":"2","key":"2019111808211012000_B21","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/nar\/gkq776","article-title":"Human box C\/D snoRNAs with miRNA like functions: expanding the range of regulatory RNAs.","volume":"39","author":"Brameier","year":"2011","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2019111808211012000_B22","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1673-8527(08)60134-4","article-title":"Implication of snoRNA U50 in human breast cancer.","volume":"36","author":"Dong","year":"2009","journal-title":"J Genet Genomics"},{"issue":"7","key":"2019111808211012000_B23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/hmg\/ddm375","article-title":"SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer.","volume":"17","author":"Dong","year":"2008","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2019111808211012000_B24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.molcel.2008.10.017","article-title":"A human snoRNA with microRNA-like functions.","volume":"32","author":"Ender","year":"2008","journal-title":"Mol Cell"},{"issue":"2","key":"2019111808211012000_B25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1128\/MCB.01128-09","article-title":"Dyskerin ablation in mouse liver inhibits rRNA processing and cell division.","volume":"30","author":"Ge","year":"2010","journal-title":"Mol Cell Biol"},{"issue":"7","key":"2019111808211012000_B26","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/hmg\/ddp585","article-title":"The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and regulates alternative splicing.","volume":"19","author":"Kishore","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"5758","key":"2019111808211012000_B27","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1126\/science.1118265","article-title":"The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C.","volume":"311","author":"Kishore","year":"2006","journal-title":"Science"},{"issue":"9","key":"2019111808211012000_B28","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/leu.2012.111","article-title":"Specific small nucleolar RNA expression profiles in acute leukemia.","volume":"26","author":"Valleron","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"2019111808211012000_B29","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2010.05.022","article-title":"Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17\/TH1 and regulatory T cells.","volume":"126","author":"Vocanson","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2019111808211012000_B30","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1172\/JCI44635","article-title":"Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells.","volume":"121","author":"Narsinh","year":"2011","journal-title":"J Clin Invest"},{"issue":"13","key":"2019111808211012000_B31","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/hmg\/11.13.1527","article-title":"Identification of tandemly-repeated C\/D snoRNA genes at the imprinted human 14q32 domain reminiscent of those at the Prader-Willi\/Angelman syndrome region.","volume":"11","author":"Cavaill\u00e9","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"9","key":"2019111808211012000_B32","doi-asserted-by":"crossref","first-page":"e1000507","DOI":"10.1371\/journal.pcbi.1000507","article-title":"Human miRNA precursors with box H\/ACA snoRNA features.","volume":"5","author":"Scott","year":"2009","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"2019111808211012000_B33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1086\/342408","article-title":"Evidence for the role of PWCR1\/HBII-85 C\/D box small nucleolar RNAs in Prader-Willi syndrome.","volume":"71","author":"Gallagher","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2019111808211012000_B34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1200\/JCO.2008.17.4870","article-title":"Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.","volume":"27","author":"Reimer","year":"2009","journal-title":"J Clin Oncol"},{"issue":"35","key":"2019111808211012000_B35","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1200\/JCO.2011.36.5411","article-title":"Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study.","volume":"29","author":"Lamant","year":"2011","journal-title":"J Clin Oncol"},{"issue":"10","key":"2019111808211012000_B36","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","article-title":"Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas.","volume":"25","author":"Ballester","year":"2006","journal-title":"Oncogene"},{"issue":"3","key":"2019111808211012000_B37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/hon.781","article-title":"Peripheral T-cell lymphoma gene expression profiles.","volume":"24","author":"Martinez-Delgado","year":"2006","journal-title":"Hematol Oncol"},{"issue":"4","key":"2019111808211012000_B38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/hon.897","article-title":"Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?","volume":"27","author":"Fornari","year":"2009","journal-title":"Hematol Oncol"},{"issue":"6892","key":"2019111808211012000_B39","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature00769","article-title":"A large nucleolar U3 ribonucleoprotein required for 18S ribosomal RNA biogenesis.","volume":"417","author":"Dragon","year":"2002","journal-title":"Nature"},{"issue":"6","key":"2019111808211012000_B40","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1128\/EC.3.6.1619-1626.2004","article-title":"The small-subunit processome is a ribosome assembly intermediate.","volume":"3","author":"Bernstein","year":"2004","journal-title":"Eukaryot Cell"},{"issue":"4","key":"2019111808211012000_B41","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1074\/jbc.M110.157842","article-title":"A small ribosomal subunit (SSU) processome component, the human U3 protein 14A (hUTP14A) binds p53 and promotes p53 degradation.","volume":"286","author":"Hu","year":"2011","journal-title":"J Biol Chem"},{"issue":"35","key":"2019111808211012000_B42","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1200\/JCO.2011.36.5411","article-title":"Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study.","volume":"29","author":"Lamant","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111808211012000_B43","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1093\/nar\/gkq1355","article-title":"Identification of human miRNA precursors that resemble box C\/D snoRNAs.","volume":"39","author":"Ono","year":"2011","journal-title":"Nucleic Acids Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/19\/3997\/1359231\/zh804512003997.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/120\/19\/3997\/1359231\/zh804512003997.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T13:42:10Z","timestamp":1574084530000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/120\/19\/3997\/30664\/Small-nucleolar-RNA-expression-profiling"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,8]]},"references-count":43,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2012,11,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-06-438135","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,8]]}}}